Macrophage colony-stimulating factor (CSF1 or M-CSF) and interleukin 34 (IL34) are secreted cytokines that control macrophage survival and differentiation. Both act through the CSF1 receptor (CSF1R), a type III transmembrane receptor tyrosine kinase. The functions of CSF1R and both ligands are conserved in birds. We have analyzed protein-coding sequence divergence among avian species. The intracellular tyrosine kinase domain of CSF1R was highly conserved in bird species as in mammals but the extracellular domain of avian CSF1R was more divergent in birds with multiple positively selected amino acids. Based upon crystal structures of the mammalian CSF1/IL34 receptor-ligand interfaces and structure-based alignments, we identified amino acids involved in avian receptor-ligand interactions. The contact amino acids in both CSF1 and CSF1R diverged among avian species. Ligand-binding domain swaps between chicken and zebra finch CSF1 confirmed the function of variants that confer species specificity on the interaction of CSF1 with CSF1R. Based upon genomic sequence analysis, we identified prevalent amino acid changes in the extracellular domain of CSF1R even within the chicken species that distinguished commercial broilers and layers and tropically adapted breeds. The rapid evolution in the extracellular domain of avian CSF1R suggests that at least in birds this ligand-receptor interaction is subjected to pathogen selection. We discuss this finding in the context of expression of CSF1R in antigensampling and antigen-presenting cells.
phenotypic consequences differ depending on genetic background and species but include osteopetrosis and postnatal growth retardation. 4, 5 Conversely, administration of CSF1 to mice, rats, or pigs produces a monocytosis and expansion of tissue macrophage populations. [6] [7] [8] In humans, gain-of-function coding mutations in CSF1R have been associated with an autosomal-dominant human neurodegenerative disease, 9, 10 while two recent studies describe recessive loss-offunction CSF1R mutations 11, 12 that share skeletal abnormalities with the mouse and rat Csf1r knockouts. Variants at the CSF1 locus are strongly associated with Paget's disease. 13 Differences in phenotype of Csf1r −/− mice compared to a spontaneous Csf1 mutation (Csf1 op/op ) mice suggested the existence of a second CSF1R ligand, which was subsequently identified and named interleukin 34 (IL34). 14 
Mutation
of the Il34 locus in mice revealed a specific function in development of subsets of tissue macrophages in skin and brain, where the gene is most highly expressed. 15 The two CSF1R ligands appear functionally equivalent. IL34 expressed under the control of the CSF1 promoter rescues the Csf1 op / op phenotype. 16 The CSF1R system of two ligands binding to one receptor was shown to be conserved throughout vertebrates, including birds 17 and fish. 18 An intronic enhancer that controls CSF1R expression is also conserved from reptiles to mammals. 19 Recombinant CSF1 administered to chicks produced a massive expansion of blood and tissue macrophage populations. 20 Solution of the tertiary structures of mouse and human CSF1 revealed the characteristic four alpha helices with two beta sheets, a structure shared by a large family of cytokines. The 3D structures of human/mouse IL34 also highlighted four antiparallel alpha helices, but with two shorter beta sheets partially replaced with an additional three alpha helices. Subsequent studies revealed the distinctive structures of the complexes between CSF1, IL34, and the receptor. [21] [22] [23] The CSF1R protein consists of five extracellular, Ig-like domains (D1-D5), a short transmembrane domain (TM), and an intracellular TK domain. The two N-terminal Ig-like domains (CSF1R D2-D3 ) mediate ligand binding while the two extracellular Ig-like domains (CSF1R D4-D5 ) are involved in receptor dimerization, which is required for downstream signaling (reviewed in Ref. 3) .
Most immune proteins are subjected to an "arms-race" between host and pathogen and experience a strong positive selective pressure. 24, 25 With some caveats, 26 nonsynonymous (amino acid altering) to synonymous substitution rate ratio ( = dN/dS) provides a measure of natural selection at the protein level, where = 1, > 1, and < 1 indicate neutral evolution, purifying, and positive selection, respectively. 27 The average dN/dS ratio of annotated immune-associated genes is up to four times higher than the genomewide average for protein-coding genes. 24, 25 Previous analysis on limited datasets indicated that both CSF1 and CSF1R were subject to positive selection in birds, whereas IL34 was subject mostly to purifying selection. 17 Since the original characterization of the CSF1R system in chicken and zebra finch 17 the Avian Phylogenomic Consortium 28 completed the draft genome sequences for 48 bird species, representing all extant clades and many targeted projects since that time have further expanded the number of partial or complete genomes to >300 and the pool of predicted protein sequences for genes expressed in avian immune cells. Among many applications, these data permitted a re-evaluation of the gene content of avian genomes and global analysis of dN/dS ratios. 29 The expanded number of genomic sequences has added greatly to the diversity of avian predicted CSF1R, CSF1, and IL34 protein sequences. The current study takes advantage of the multispecies genomic dataset to examine the contrasting evolutionary constraints on the CSF1R system in birds and mammals.
MATERIALS AND METHODS

Sequence collection and multiple sequence alignment
Avian CSF1, IL34, and CSF1R protein and gene sequences were retrieved from the National Centre for Biotechnology Information (NCBI; http://ncbi.nlm.nih.gov) and completed avian genomes were analyzed by Avian Phylogenetic Consortium. 28 Accession numbers for all protein sequences are provided in Supplementary Table 4 . 
Structural modeling
Phylogenetic analysis
An MSA for avian sequences was created using CLUSTALW and phylogenetic analysis generated by nearest neighbor joining (MacVec- 
Searching for protein coding variants in CSF1R, CSF1, and IL34 genes in commercial and village chicken populations
Sequence and variant data from a number of chicken populationsboth commercial and noncommercial village chicken populationswere screened for the presence of protein coding variants from the genes CSF1R, CSF1, and IL34. Variant data on commercial broilers and layers originated from previous studies. 31 Full annotation of the whole genome sequences and analysis of genetic diversity of these chicken populations will be published elsewhere.
Cross-species reactivity of recombinant chicken CSF1 proteins on growth and differentiation of avian BM-derived macrophage precursors
For each avian species examined (chicken, turkey, zebra finch, quail, and duck), 3-week-old birds were sacrificed and BM cells were obtained by flushing the marrow from two femurs and two tibias with PBS using a syringe and a blunt needle. For each preparation, cells were pelleted and resuspended in 4 mL complete RPMI (supplemented with 10% heat-inactivated FCS, 2 mM L-glutamine, 100 µg/mL penicillin, and 100 µg/mL streptomycin) containing 350 ng/mL recombinant chicken CSF1 (chCSF1). Cells were plated in 60 mm bacteriological plates (10 6 cells/mL) and incubated at 37 • C in a CO 2 incubator for 8 days. After 4 days of incubation, fresh media supplemented with chCSF1 was added. Media containing the recombinant cytokine was exchanged every 2 days there afterwards. Biological activity was confirmed by visual examination of the plates for the formation of adherent macrophage cells and by harvesting and counting the cells.
Each experiment was conducted in triplicate.
Construction of chicken and zebra finch CSF1 receptor domain swapped CSF1 proteins
Four constructs were designed and synthesized by GeneArt (Life Technologies, Renfrew, UK). These synthetic DNA expression constructs encoded either the mature 189 amino acid long peptides of chCSF1 (M1-P189) and zfCSF1 peptides or the two domain swapped constructs, zfCSF1 containing the predicted chicken ligand binding Site 1 residues T86 to E111 and the chCSF1 containing the zebra finch residues K87 to N112 inclusive (note the construct includes the signal peptide and the numbering of amino acids refers to the full-length protein). All four expression constructs contained attB flanking regions for Gateway cloning (Life Technologies, Renfrew, UK). The "One-tube" protocol using the Gateway BP and LR Clonase II enzyme mix was used.
Constructs were first introduced into an entry vector pDONR221 and then immediately into the destination expression vector pDEST51 containing V5 and 6xHis tags. Note that 50 µL of Top10 competent Escherichia coli was transformed with 1 µL of each construct using a standard transformation protocol. Bacterial colonies were expanded and DNA was extracted using EndoFree Plasmid Maxi Kit (Qiagen, Manchester, UK).
Assay of the biological activity of chicken and zebra finch CSF1 proteins using growth factor dependent cells
We have previously established a bioassay for chicken CSF1 by stably transfecting the interleukin 3 (IL3)-dependent BaF3 cell line with a chCSF1R expression plasmid. 17 The transfected BaF3 cells express chCSF1R on the cell surface 33 and are able to survive and proliferate in the presence of chCSF1. HEK293 cells were transfected with expression plasmids for chCSF1, zfCSF1, zf_chCSF1, or ch_zfCSF1 and supernatants were collected. BaF3/chCSF1R cells were cultured with 20%
HEK293T supernatant. A negative control had no added growth factor, while 5% conditioned medium from X63 Ag8-653 myeloma cells carrying an expression vector for IL-3 provided a positive control. 17 Cells were cultured at 2 × 10 4 cells per well in a total volume of 100 µL complete DMEM supplemented with an appropriate amount of HEK293 supernatant and grown for 48 h at 37 • C in a 96-well plate. Viable cells were assayed as described previously. 17 Ten microliters of 3-(4 5-di methyl thiazol-2-yl)-2 5-diphenyltetrazolium) solution (final concentration 1 mg/mL) was added to each well and incubated at 37 • C for 3 h.
Then, 100 µL of solubilization solution (acid isopropanol) was added to each well and the absorbance was read at 570 nm. 
Production of recombinant avian CSF1 in HEK293 cells
RESULTS
Sequence analysis of the CSF1 ligand-receptor system from birds and mammals
From available genomic DNA sequences and entries in NCBI GenBank, we were able to extract 68 CSF1R, 30 IL34, and 36 CSF1 predicted full-length protein sequences orthologous to the functional chicken proteins analyzed previously. 17 The relative paucity of avian CSF1 and IL34 sequences available reflects the difficulties in sequencing in the respective genomic regions, in common with multiple other GCrich regions, in all avian genomes. 29 In many cases, the sequences annotated as CSF1 or IL34 in NCBI as a predicted protein were truncated at the N terminus relative to full-length chicken and zebra finch orthologs. Multiple sequence alignments (MSAs) of each of the avian CSF1, IL34, and CSF1R protein-coding regions are provided in Supplementary Table 1A -C. In mammals, the CSF1 locus encodes multiple isoforms of the protein generated by alternative splicing. 3 The longest cDNA encodes a membrane-bound precursor that is cleaved from the cell surface by TNF-alpha converting enzyme (TACE, ADAM17) 34 to release the minimal bioactive CSF1 protein. In transgenic mice, this longer form of the ligand is required to fully complement a CSF1 mutation and restore postnatal growth. 35 Consistent with previous evidence of the production of longer forms of CSF1 mRNA in chickens, 17 The short intracellular domain contains a membrane-proximal basic region that is conserved between mammals and birds. The remainder of the intracellular domain is also strongly conserved in birds. Similar membrane proximal basic domains are found in many membraneassociated proteins including G protein-coupled receptors. The intracellular domain may function to promote membrane trafficking from the Golgi 36 or conceivably also produce a reverse signal to the CSF1producing cell. 37 The intervening region between the bioactive peptide and membrane is longer in mammals than in birds. In common with many proteolytic cleavage domains, the obvious conserved feature is repeated proline (P), glutamate (E), serine (S), and threonine (T) amino acids.
At the N terminus, we also noted that there was considerable ambiguity among predicted protein sequences in GenBank regarding the location of the start codon and the length of the leader sequence.
For the purpose of the current analysis, we have aligned the processed peptide containing the 160 amino acids that make up the minimal bioactive 4-helix bundle. 17 In the case of IL34, the predicted avian proteins are all around 180 amino acids, truncated at the C-terminus relative to predicted mammalian IL34 proteins (230-240 amino acids).
In mammals, some of the C-terminal amino acids were found to be engaged in binding to CSF1R 23 but in birds the 180 amino protein contains the biological activity. 17 As noted based upon comparison of chicken and zebra finch, 17 the avian CSF1 sequences all showed conservation of cysteines that provides a strong reference framework for the alignment ( Supplementary   Table 1A ). These conserved avian residues are predicted to form three intrachain disulfide bonds coincident with the cysteines involved in disulfide bonds in CSF1 of mammals and fish. 17 In all of the avian CSF1 peptides, the cysteine responsible for the interchain disulfide bond in mammalian CSF1 is substituted with glycine (G29 in Supplementary   Table 1A ; position 63 in Fig. 1 ). Nevertheless, the chicken protein forms a dimer through predicted large hydrophobic interfaces. 17 Early studies indicated that the interchain disulfide in human CSF1 was absolutely required for dimerization and biological activity, but this does not appear to be the case. 38 Mutation of this cysteine (C31S, numbered in the mature CSF1 peptide without the leader sequence) did not compromise refolding or biological activity of recombinant human CSF1.
Based upon structural analysis, two amino acids (Q26 and M27) were predicted to make strong contributions to dimer formation. 38 These are conserved in all bird and mammalian CSF1 sequences (Q25/M26 in the active mature chicken sequence shown in Supplementary Table 1A ;
positions 58/59 in Fig. 1 ). Indeed, D23, which made strong electrostatic and nonpolar contributions to the dimer interface in the C31S mutant human protein, is also conserved between birds and mammals and in all birds ( Supplementary Table 1C ). A second shorter segment in CSF1 that contributed to the dimer interface, R66-N73 in human CSF1 (positions 98-107 in Fig. 1 ), is also conserved between mammals and birds and the core (FKENS) is identical in all bird species. A combined C31S/M27R mutation produced a monomeric CSF1 that acted as a CSF1R antagonist. The absence of cysteine in this location in the avian ligand suggests that the C31S mutation in the mammalian protein is unlikely to be necessary to achieve this outcome. Our earlier analysis of available CSF1 sequences indicated significant divergence among species and evidence of positive selection. 17 This conclusion was confirmed using the larger dataset. 30 Figure 2 shows a neighborjoining phylogenetic tree for the available sequences. This simple analysis reveals that the Galloanseriformes (chicken, turkey, guinea fowl, quail, and goose) clearly form a separate group.
Avian IL34, unlike CSF1, is subject to purifying selection. 17 Indeed, although CSF1 is highly divergent between birds and mammals, the core 145 amino acid chicken IL34 protein, excluding the leader sequence, is around 60% identical to the human protein and can be readily aligned (not shown). Despite this level of conservation, amino acid differences among mammalian species were associated with species-specific biological activity. 39 Supplementary Table 1B shows the MSA of the available avian IL34 proteins.
The intracellular domain of CSF1R including all of the tyrosines that undergo phosphorylation to initiate signaling is conserved from birds to mammals. MSA of avian CSF1R peptides reveals strong conservation of the transmembrane and intracellular TK domains ( Supplementary Table 1C ). The catalytic amino acids required for TK activity, the tyrosine residues that are autophosphorylated in response to receptor ligation, 3 and those involved in autoinhibition revealed by the crystal structure of the kinase domain of mammalian CSF1R 40 are conserved in all birds. This conservation is consistent with functional studies in which the chicken CSF1R was able to signal when expressed in mammalian growth factor-dependent cells. 17 inactive on the chicken receptor. 17 The arginine substitution is present in all bird sequences.
The topology of CSF1R extracellular domains is conserved and the cysteine residues in the five predicted Ig-like domains (D1-D5) in the extracellular domain of CSF1R are present in all available bird sequences. This provides a clear framework for structure-based alignment that is almost gap free ( Supplementary Table 1C ) and construction of a phylogenetic tree based upon the aligned sequences as shown in Supplementary Table 1A . A neighbor joining phylogenetic tree was then generated using the same package. Supplementary Table 1C . A neighbor joining phylogenetic tree was then generated using the same package.
a much larger assembly of avian species 41 (see the phylogenetic tree image from this study in the graphical abstract, reproduced with permission) and recapitulates analysis based upon the divergence of the conserved intronic enhancer in the CSF1R locus. 19 As in the case of CSF1, the Galloanserae form a divergent group.
The overall sequence identity between the most disparate CSF1R protein sequences (e.g., between chicken and zebra finch), around 75%, is similar to the conservation between the most divergent mammalian sequences (primates and rodents 39 ) but the pattern of variation among species is different. The majority of substitutions/insertions among bird species occur in the region between domains 3 and 4, and in a small number of hypervariable regions. We repeated the dN/dS analysis using the larger dataset now available. Figure 4 shows a comparison of the profiles for avian and mammalian CSF1R relative to the predicted domain structures. A total of 15 amino acids showed ɷ > 1 in the avian lineages.
Cross-species specificity of the CSF1 ligand in birds
The tertiary structures of CSF1, IL34, and CSF1R in the chicken were modeled previously based upon published mammalian structures. The results were consistent with strong conservation of the tertiary structure. 17 Subsequently crystal structures of mammalian CSF1R/CSF1 and CSF1R-IL34 complexes have been reported. [21] [22] [23] 42, 43 In each case, ligand binding involves interaction Based upon the structural analyses, we predicted the candidate Sites 1 and 2 regions of interaction for the avian CSF1/CSF1R and IL34/CSF1R complexes. The alignments of these regions from the most divergent chicken and zebra finch sequences and the corresponding human sequences are provided in Table 1 divergence also distinguishes chicken, quail, and turkey from duck and goose. The structure-based alignment of predicted contact residues in CSF1 reveals corresponding variation in Site 1 of the ligand, in particular multiple nonconservative substitutions between chicken T57 and E82, whereas Site 2 on CSF1 is conserved across all available avian sequences. The Site 1 interaction between chCSF1 and chCSF1R is predicted to involve a salt bridge between K73 in the ligand and E168 and E170 in the receptor ( Table 2 ). This interaction is abolished in the zebra finch receptor (Q164, S166); substitutions shared by many bird species ( Supplementary Table 1C ). Conversely, the zebra finch ligand has two charged amino acids, E60 and E63, that are likely to form salt bridges with R142 and K147 in chicken CSF1R (similar salt bridges exist between CSF1 E62/D63 and CSF1R R142/R146 in the human CSF1-CSF1R complex).
Felix et al. 43 also identified the structural basis for ligand-induced dimerization involving amino acids in Ig-like domain D4 of the receptor.
In the human receptor, this interaction involves salt bridges between R370 and E375 across the dimer interface, a mechanism that is conserved among type III TK receptors. This region (highlighted in Supplementary Table 1C ) can be aligned with mammalian CSF1R and the corresponding glutamate (E) residue is conserved across most bird species. The precise location of basic amino acids that contribute to dimerization may vary among the species.
In mammals, sequence variation in the ligand binding sites of the CSF1/CSF1R complex constrains cross-species reactivity. 39 For example, mouse CSF1 is not active on the human CSF1R, but is active on pig, while human and pig CSF1 are active on all three species. 39 Based upon the sequence analysis and structural models, we predicted that there would also be major constraints on cross-species reactivity of CSF1 between the most divergent species exemplified by chicken and zebra finch. To test this hypothesis and indirectly confirm the accuracy of the structural model, bone marrow (BM) cells from several avian species were treated with recombinant chicken CSF1 (chCSF1). This system has been used before to generate bone marrow-derived macrophages (BMDM) from the chicken for functional studies. Chicken BMDM generated in response to CSF1 were actively phagocytic, responded to lipopolysaccharide, and expressed macrophage-specific transcripts detectable by RNAseq. 17 Despite the variation in D2 and D3 between these species, chCSF1-stimulated cell survival and proliferation of BM cells from chicken, quail, turkey, and also duck and gave rise to a monolayer of macrophage-like cells within 7 days. By contrast, zebra finch BM cells died when cultured with chCSF1 with no mature macrophage-like cells present in the wells after 7 days (not shown). To test whether the amino acid differences in Site 1 of CSF1 were sufficient to explain the species specificity, we generated expression constructs encoding chCSF1, zfCSF1, and two domain TA B L E 1 Sequence divergence between chicken and zebra finch in the interaction sites between CSF1R and its ligands, CSF1 
CSF1R-IL34
Site I Human E119 R142 V143* R144 G145* R146 P147* L148 M149* R150 H151* K168 F169 I170* S172 Q173* D174 Q176 Chicken K119 R142 N143 D144 G145 S146 K147 L148 S149 P150 G151 E168 H169 E170 K172 G173 Q174 Q176 Zebra finch K115 M138 E139 N140 A141 P142 S143 L144 P145 P146 G147 Q164 N165 S166 K168 G169 S170 R172
Site II
For the predicted CSF1-CSF1R interaction, the binding Sites 1 and 2 are based upon structure-based alignment of available human and mouse CSF1-CSF1R (D1-D3) and IL34-CSF1R (D1-D3) structures. Contact amino acids in CSF1 and CSF1R derived from the human structures are highlighted in gray, and asterisks indicate amino acids that differ between human and mouse. Where the corresponding amino acids diverge between zebra finch and chicken, they are set in bold.
swaps in which the variable regions of Site 1 in zebra finch CSF1 (K57-N82) was replaced with the homologous residues in chicken CSF1
(T57-E82) (zf_chCSF1) and vice versa (in zebra finch CSF1 (ch_zfCSF1).
Four constructs were expressed in HEK293T cells and supernatants containing recombinant CSF1 were tested. The supernatants from HEK293 cells transfected with zfCSF1 expression plasmid were able to promote survival of BaF3 cells expressing the chicken CSF1R to the same extent as supernatants from cells expressing chCSF1 (Fig. 5 ).
Both of the domain-swapped constructs zf_chCSF1 and ch_zfCSF1
were also active on the chCSF1R reporter cell line (Fig. 5A ). We then tested the ability of each of the supernatants to promote the differentiation of chicken BM and zebra finch BM. The zebra finch BM cells survived and clearly differentiated to form a monolayer of macrophage-like cells in response to zfCSF1, whereas in chCSF1 no live cells remained in the cultures after 7 days. The domain swap in which chCSF1 contains K57-N82 from zfCSF1 (ch_zfCSF1) was also active on zebra finch marrow (Fig. 5B) The chicken and zebra finch CSF1R complexes were modeled based upon the human CSF1-CSF1R (D1-D3) structure as described in Materials and Methods section. Non-conserved amino acids are set in bold. Site 1 of the chicken ligand (ch_zfCSF1) abolished the activity on zebra finch marrow. This observation confirms that the difference in crossspecies reactivity between chicken and zebra finch CSF1 ligands can be attributed to the variation in receptor binding Site 1 (Table 1 ).
Polymorphism in the CSF1R, CSF1, and IL34 genes among selected chicken populations
Western commercial chickens have been subject to intensive selection of production traits: rapid growth and meat production or egg laying.
Selection has produced genomic signatures that can be detected as extended regions of homozygosity. 44 In mammals, mutations in CSF1 or CSF1R produce severe postnatal growth retardation suggesting a link between macrophages and the growth hormone/IGF1 axis. 3, 5 Indeed, the CSF1R gene on chromosome 13 lies within an interval containing signatures of selection 44 and 42 separate quantitative trait loci (QTL) (https://www.animalgenome.org/QTLdb) almost all associated with growth-related traits. We examined the impact of sequence variants among commercial birds (Supplementary Table 2 ). Proteincoding variants affecting CSF1, CSF1R, and IL34 were detected in pedigree lines of commercial broilers and layers sequenced to produce the avian high-density SNP chip. 31, 32 Variants in CSF1 and IL34 were detected with minor allele frequencies (MAF) > 0.2 in specific lines of layers and broilers. None of the variants in CSF1 affects contact amino acids but V45G, L54S, V121G, F124H, and L132M each alter amino acids that are conserved across all other bird species ( Supplementary   Table 1A ). Although N87D is recorded as a variant in one broiler line, all other avian sequences have an asparagine (N) in this position and this is clearly also the common sequence in commercial birds. N87D
is predicted to be a deleterious substitution but our original chicken CSF1 cDNA 17 encodes D87 and was expressed as an active protein.
In the case of CSF1R, consistent with evidence of selective sweeps in the genomic region, several protein-coding variants were detected with high MAF in specific broiler or layer lines. One variant, G414S, was universal in commercial birds (and also in African birds, below). Duck and goose each have a glycine (G) in this position, whereas turkey, quail, and guinea fowl have serine (S). So, this variant is probably a difference distinguishing domestic chickens from red jungle fowl.
A different selection pressure including heat stress and disease applies to indigenous chicken ecotypes selected for resilience and survival in tropical small holder systems. 45 We predicted that genes such as CSF1 and CSF1R that diverge rapidly between species might also exhibit functional polymorphism within a species occupying many diverse environmental niches. We therefore explored genomic DNA sequences from tropically adapted village chicken populations from multiple climatically diverse regions of Ethiopia and Nigeria. The results are shown in Supplementary Tables 3. Within the CSF1R gene in Ethiopian birds, we identified 13 nonsynonymous protein-coding variants with prevalent allele frequencies, all but one within the extracellular domain. Five of these variants were unique to the Ethiopian birds, whereas others were previously assigned SNP IDs during development of the 600,000 high-density SNP chip and have useful heterozygosity across commercial broiler and layer lines. 31, 32 F125L (common to broilers and layers); N153S, S409L, and I468L (broiler-specific); and R294W and A308T (layer-specific) were also detected with variable frequency in most Ethiopian and Nigerian populations, perhaps reflecting admixture of Western birds. Among the variants shared by commercial and tropically adapted birds, none impacted amino acids implicated in ligand binding identified in Table 1 and most vary to some extent between species. Position F125 is also leucine (L) in most other avian species; position N153 is serine (S) in two species of tit, starling, and ruff and position 308 is threonine (T) in 2 manakin species (blue-crowned and golden-crowned) and glycine (G) in cuckoo roller ( Supplementary Table 1C ). Positions 294, 409, and 468 have more than one substitution across species, including the chicken variant.
One of the novel coding variants in tropically adapted birds, D91N, was detected in 26/27 Ethiopian populations with an average allele frequency of 0.32 (range 0.05-0.67). The same variant was detected in around half of the Nigerian populations with a lower MAF (average 0.08). This amino acid lies within a region of D2 that is conserved across bird species ( Supplementary Table 1C ). The D to N substitution requires a single base change but that substitution is predicted in only one other species, the Kea. Accordingly, we suggest that this change is due to some form of positive selection among the tropically adapted chickens in Ethiopia. Only five coding variants were detected in IL34 from African populations, of which only one, R127Q, was prevalent in multiple Ethiopian populations (Supplementary Table 3 ). This amino acid is conserved in bird species but lies outside the binding site for the receptor. In the biologically active portion of CSF1, we identified the N87D variant discussed above at low allele frequency in the majority of populations and a small number of rare potentially deleterious variants at low frequency in specific populations (Supplementary Table 4 ). None of the variants altered contact amino acids. One other variant detected in all Ethiopian populations, E99K, is also present in duck and goose, but not in quail or guinea fowl reference sequences.
DISCUSSION
We have combined structural predictions and evolutionary analysis retained the ability to activate chCSF1R, whereas chCSF1 was inactive on zfCSF1R. Domain swap analysis confirmed that the amino acids K57-N82 within zfCSF1 (Site 1) that interact with domain D2 of CSF1R are both necessary and sufficient to enable activation of zebra finch BM cells. There are six amino acid differences between the two species in this short segment, all involving charged amino acids ( Table 1) . As discussed above, we suggest that the binding affinity of chicken CSF1 for chicken CSF1R depends upon charged amino acid interactions.
By contrast, there appear to be no predicted salt-bridge interactions in zebra finch CSF1 binding to its receptor, but two charged amino acid substitutions may permit the formation of salt bridges to the chicken receptor.
The analysis of many more IL34 sequences in birds ( Supplementary   Table 1B ) confirmed that unlike CSF1, this protein is under strong negative selection. Notwithstanding the high conservation in mammals, human IL34 is not active on the mouse CSF1R, and vice versa, but both were equally active on pig CSF1R. 39 Aside from the conserved basic amino acid contacts that are shared with CSF1, many of the orthologous positions to the contact amino acids bound by IL34 in human CSF1R also vary between avian species. 23 Although IL34 is highly conserved overall across avian species, the variation that does exist is focused in several of the contact amino acids in Site 1 of IL34, and there are corresponding changes in predicted contact amino acids in domain 2 (Site 1) of CSF1R (Supplementary Table 2 ). The strong negative selection acting on other parts of the IL34 sequence thus appears unrelated to binding to CSF1R. Indeed, there is evidence for IL34 interaction with two separate partners in mice, a protein tyrosine phosphatase 46 and syndecan-1. 47 The function of IL34 in birds has not been studied beyond the demonstration that the protein is active on the chicken CSF1R. 17 The most striking feature of our analysis, which clearly distinguishes birds from mammals, is the hypervariability of the CSF1/IL34 binding Site 1 in CSF1R. Why has selection in avian evolution apparently acted upon ligand binding to CSF1R? One major difference between birds and mammals lies in the expression of CSF1R. We developed monoclonal antibodies against CSF1R 33 and a transgenic chicken line expressing reporter genes from the CSF1R promoter region. 48 Combined analysis using these resources revealed the exceptionally high level of expression of CSF1R on antigen-capturing cells (follicle-associated epithelium [FAE]) in the bursa and lymphoid follicles (Balic A. et al., forthcoming) and in the respiratory tract. 49 These cells are unique to birds, which unlike mammals, lack lymph nodes. They are the functional equivalent of microfold (M) cells in mammals, the major site of luminal antigen sampling and pathogen invasion in intestinal mucosa. 50 In mammals, CSF1R is not expressed by M cells, although CSF1R-dependent macrophages in the lamina propria of the intestine control M cell differentiation. 51 In a second contrast with mammals, we found that CSF1R is highly expressed by antigen-presenting dendritic cells, which are a prevalent cell population in the avian liver in addition to their well-recognized prevalence in bursa and spleen. 52 So, we suggest two nonexclusive explanations.
One is that a class of pathogen-associated virulence determinants acts to block binding of CSF1 or IL34 in order to compromise innate immunity or the function of FAE. Such a pathogenicity determinant exists in the form of the immunomodulatory BARF1 viral protein, which binds to human CSF1R. 43 A second nonexclusive explanation is that a pathogen or pathogen-associated molecule binds to CSF1R to enable receptor-mediated internalization. CSF1R is expressed on the cell surface and upon ligand binding promotes endocytosis of the ligand, either CSF1 or IL34. 3 Hence CSF1R could provide a portal for pathogen invasion.
The secondary question is how evolution in CSF1R can occur without compromising the innate immune system. CSF1 and CSF1R knockout mutations in mice and rats 4, 5 are macrophage deficient and have severe developmental abnormalities. This is also the case in zebra fish. 12 We have recently confirmed based upon CRISPR-mediated knockout in the germ line that the chicken CSF1R is also absolutely required for posthatch development (Balic A. and DAH, forthcoming).
Accordingly, loss of function mutations in CSF1R that abolish CSF1 binding in birds are unlikely to be tolerated as homozygotes and in the absence of a heterozygous phenotype there would be no selection. If CSF1R is the target of pathogen selection, only changes that preserve ligand binding would be tolerated. Such variation may well change the affinity of interaction with one or other ligand, but since binding is effectively irreversible (the ligand is internalized and degraded) this would not necessarily have any phenotypic impact. Lineage-specific evolution of CSF1 and IL34 subsequent to receptor divergence could occur by drift or positive selection to increase ligand binding affinity with consequent loss of binding to ancestral forms of the receptor.
Based upon the phylogenetic tree, and the conservation of the majority of the zfCSF1 ligand variants in this region across distantly related species (kiwi, emu, emperor penguin, golden eagle), we suggest that zfCSF1 resembles the ancestral avian CSF1 sequence and the ability of this ancestral form of CSF1 to bind the CSF1R in chickens has been preserved across evolution. By the same argument, CSF1 from large animals including humans could be considered the ancestral form that retains binding to rodent CSF1R. We have not carried out the same functional analysis of IL34. Any pathogen that targets CSF1R would likely impact on both CSF1 and IL34 actions. Some contact amino acids in the receptor are shared within the hypervariable region of D2. The alignment in Supplementary Table 1B and analysis in Table 1 reveal that there are corresponding changes in Site 1 of IL34. Among the avian sequences we have analyzed, variants in Site 1 distinguish the galliforms (chicken, quail, and turkey) from all the other species.
Previous studies of birds in smallholder systems in Ethiopia provided strong evidence for heritable disease resistance and resilience. 45 Comparative analysis of available sequences of western commercial and tropically adapted populations identified prevalent protein sequence variants (Supplementary Tables 2 and 3 ). Some CSF1R variants distinguished layer and broiler lines consistent with evidence of signatures of selection in broiler lines in this region of chromosome 13 44 and QTL association with growth-related traits. CSF1R
is clearly highly polymorphic in chickens and the coding variants distinguish western commercial birds from tropically adapted birds.
By contrast, the much larger exome sequence database for humans (exac.broadinstitute.org) reveals 305 missense variants in CSF1R, but all except H362R (MAF = 0.19) are rare (MAF < 0.01). H362 is not conserved in other mammals. Amino acid 362 lies within the receptor dimerization domain D4. Surprisingly, the H362R variant is strongly overrepresented (MAF 0.4) in East Asian populations and was associated with reduced receptor dimerization and altered CSF1 responsiveness. 53 Conversely, numerous synonymous coding variants and noncoding intronic variants in human CSF1R have MAF > 0.3.
Two common variants that distinguish commercial broilers and layers,
A308T and S409L, also occur within domain 4 but whether they influence CSF1R function is unknown. Common variants detected in commercial birds are relatively rare in Ethiopian and Nigerian populations and one CSF1R variant D91N was prevalent and unique to Ethiopia and Nigeria. Each of the variants affects an amino acid that is conserved to some degree across avian species. Polymorphism is a common feature of innate immune receptors. 54 It remains to be determined whether any of these variants can be associated with disease resistance or production traits and could represent targets for markerassisted selection.
Although the focus of this study has been on the avian CSF1R system, as mentioned in the Introduction, there is emerging interest in CSF1R as a drug target 2 and in functional analysis of loss-of-function and gain-of-function mutations in CSF1R in human patients. [9] [10] [11] [12] The human and mouse equivalents of the BaF3-CSF1R we have used here to assess cross-reaction of avian CSF1 have previously used to assay function of disease-associated human mutant receptors. 9 Our findings in birds suggest that focused mutagenesis of the interaction sites of CSF1 with CSF1R could provide the basis for generation of monomeric antagonists or higher affinity agonists. 
